Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medicare | 107 | 2024 | 6881 | 8.760 |
Why?
|
Primary Health Care | 64 | 2024 | 4748 | 6.950 |
Why?
|
Medicare Part C | 19 | 2024 | 332 | 5.920 |
Why?
|
Fee-for-Service Plans | 37 | 2024 | 714 | 5.070 |
Why?
|
Physicians, Primary Care | 20 | 2024 | 623 | 4.730 |
Why?
|
Reimbursement Mechanisms | 20 | 2020 | 677 | 4.130 |
Why?
|
Physicians | 39 | 2023 | 4614 | 3.520 |
Why?
|
United States | 249 | 2024 | 73144 | 3.070 |
Why?
|
Managed Care Programs | 29 | 2016 | 942 | 2.950 |
Why?
|
Aortic Aneurysm, Abdominal | 19 | 2019 | 1252 | 2.920 |
Why?
|
Hospitalists | 5 | 2024 | 298 | 2.680 |
Why?
|
Health Expenditures | 37 | 2023 | 2395 | 2.670 |
Why?
|
Quality of Health Care | 55 | 2023 | 4339 | 2.660 |
Why?
|
Health Maintenance Organizations | 18 | 2023 | 658 | 2.660 |
Why?
|
Ambulatory Care | 21 | 2024 | 2784 | 2.530 |
Why?
|
Specialization | 17 | 2023 | 781 | 2.420 |
Why?
|
Insurance, Health | 19 | 2022 | 2518 | 2.400 |
Why?
|
Reimbursement, Incentive | 26 | 2021 | 548 | 2.370 |
Why?
|
Referral and Consultation | 20 | 2022 | 3627 | 2.210 |
Why?
|
Health Care Surveys | 34 | 2023 | 2437 | 2.190 |
Why?
|
Quality Indicators, Health Care | 34 | 2022 | 1813 | 2.160 |
Why?
|
Community Health Centers | 12 | 2017 | 469 | 2.090 |
Why?
|
Hospitalization | 29 | 2024 | 10844 | 2.070 |
Why?
|
Patient-Centered Care | 14 | 2023 | 1447 | 2.060 |
Why?
|
Quality Assurance, Health Care | 22 | 2011 | 2180 | 2.050 |
Why?
|
Medicare Part D | 4 | 2023 | 358 | 1.860 |
Why?
|
Emergency Service, Hospital | 23 | 2024 | 7955 | 1.830 |
Why?
|
Group Practice | 10 | 2021 | 151 | 1.790 |
Why?
|
Office Visits | 8 | 2023 | 596 | 1.630 |
Why?
|
Cost Savings | 17 | 2024 | 915 | 1.620 |
Why?
|
Aortic Rupture | 8 | 2016 | 322 | 1.470 |
Why?
|
Physician Assistants | 5 | 2023 | 190 | 1.450 |
Why?
|
Health Care Reform | 12 | 2018 | 1262 | 1.440 |
Why?
|
National Health Programs | 3 | 2022 | 442 | 1.420 |
Why?
|
Endovascular Procedures | 11 | 2020 | 2215 | 1.390 |
Why?
|
Nurse Practitioners | 5 | 2023 | 271 | 1.380 |
Why?
|
Hospitals | 16 | 2024 | 3905 | 1.370 |
Why?
|
Vascular Surgical Procedures | 8 | 2018 | 1515 | 1.370 |
Why?
|
Patient Readmission | 12 | 2024 | 3312 | 1.360 |
Why?
|
Community Networks | 5 | 2018 | 202 | 1.340 |
Why?
|
Aged | 134 | 2024 | 171544 | 1.340 |
Why?
|
Healthcare Disparities | 14 | 2024 | 3412 | 1.330 |
Why?
|
Practice Management, Medical | 6 | 2020 | 192 | 1.330 |
Why?
|
Back Pain | 6 | 2017 | 547 | 1.310 |
Why?
|
Deductibles and Coinsurance | 9 | 2016 | 316 | 1.270 |
Why?
|
Humans | 324 | 2024 | 768298 | 1.250 |
Why?
|
Cross-Sectional Studies | 52 | 2024 | 26373 | 1.250 |
Why?
|
Patient Protection and Affordable Care Act | 10 | 2022 | 1189 | 1.230 |
Why?
|
Electronic Mail | 3 | 2015 | 215 | 1.230 |
Why?
|
Medicine | 14 | 2022 | 948 | 1.210 |
Why?
|
Total Quality Management | 7 | 2010 | 265 | 1.160 |
Why?
|
Job Satisfaction | 7 | 2018 | 549 | 1.150 |
Why?
|
Myocardial Infarction | 8 | 2024 | 11515 | 1.130 |
Why?
|
State Health Plans | 6 | 2014 | 220 | 1.110 |
Why?
|
Capitation Fee | 5 | 2017 | 115 | 1.060 |
Why?
|
General Practitioners | 3 | 2017 | 103 | 1.040 |
Why?
|
Patient Admission | 6 | 2021 | 1367 | 1.040 |
Why?
|
Insurance Carriers | 4 | 2024 | 159 | 1.000 |
Why?
|
Chronic Disease | 17 | 2023 | 9380 | 0.990 |
Why?
|
Physician Incentive Plans | 9 | 2014 | 165 | 0.980 |
Why?
|
Long-Term Care | 3 | 2020 | 632 | 0.960 |
Why?
|
Patient Care | 6 | 2013 | 629 | 0.960 |
Why?
|
Blood Vessel Prosthesis Implantation | 7 | 2018 | 1459 | 0.950 |
Why?
|
Preferred Provider Organizations | 3 | 2023 | 37 | 0.940 |
Why?
|
Male | 180 | 2024 | 364870 | 0.940 |
Why?
|
Health Services Accessibility | 24 | 2022 | 5511 | 0.940 |
Why?
|
Medicaid | 12 | 2021 | 2842 | 0.930 |
Why?
|
Insurance Coverage | 6 | 2020 | 1946 | 0.930 |
Why?
|
Headache | 4 | 2017 | 1262 | 0.930 |
Why?
|
Crowding | 2 | 2024 | 144 | 0.920 |
Why?
|
Female | 185 | 2024 | 397050 | 0.910 |
Why?
|
Health Care Costs | 10 | 2023 | 3267 | 0.910 |
Why?
|
Analgesics, Non-Narcotic | 3 | 2015 | 371 | 0.860 |
Why?
|
Aged, 80 and over | 57 | 2024 | 59683 | 0.840 |
Why?
|
Delivery of Health Care | 15 | 2022 | 5375 | 0.820 |
Why?
|
Health Services Misuse | 5 | 2016 | 249 | 0.810 |
Why?
|
Health Services Research | 24 | 2021 | 1817 | 0.810 |
Why?
|
Early Termination of Clinical Trials | 1 | 2021 | 70 | 0.760 |
Why?
|
Certification | 6 | 2024 | 420 | 0.760 |
Why?
|
Diabetes Mellitus | 14 | 2021 | 5890 | 0.730 |
Why?
|
Hospital Mortality | 11 | 2024 | 5367 | 0.710 |
Why?
|
Internal Medicine | 7 | 2024 | 1057 | 0.700 |
Why?
|
Physicians, Family | 3 | 2017 | 349 | 0.690 |
Why?
|
Length of Stay | 7 | 2024 | 6516 | 0.690 |
Why?
|
Risk Adjustment | 8 | 2020 | 603 | 0.690 |
Why?
|
Delivery of Health Care, Integrated | 6 | 2017 | 954 | 0.670 |
Why?
|
Retrospective Studies | 50 | 2024 | 81768 | 0.660 |
Why?
|
Models, Economic | 5 | 2020 | 718 | 0.660 |
Why?
|
Patient Discharge | 10 | 2024 | 3474 | 0.660 |
Why?
|
Clinical Coding | 2 | 2018 | 186 | 0.660 |
Why?
|
Insurance Claim Reporting | 2 | 2017 | 166 | 0.660 |
Why?
|
Relative Value Scales | 1 | 2019 | 86 | 0.630 |
Why?
|
Gatekeeping | 1 | 2018 | 49 | 0.620 |
Why?
|
Clinical Competence | 13 | 2024 | 4847 | 0.620 |
Why?
|
Socioeconomic Factors | 14 | 2024 | 7861 | 0.620 |
Why?
|
Patient Satisfaction | 16 | 2016 | 3485 | 0.620 |
Why?
|
Workload | 2 | 2022 | 852 | 0.610 |
Why?
|
Physician-Patient Relations | 11 | 2016 | 3267 | 0.610 |
Why?
|
Health Services | 2 | 2014 | 756 | 0.610 |
Why?
|
Bed Occupancy | 1 | 2018 | 38 | 0.610 |
Why?
|
Dementia | 2 | 2023 | 2728 | 0.590 |
Why?
|
Preventive Health Services | 5 | 2016 | 568 | 0.580 |
Why?
|
Insurance Claim Review | 8 | 2021 | 746 | 0.580 |
Why?
|
Income | 5 | 2022 | 1877 | 0.570 |
Why?
|
Contracts | 5 | 2022 | 60 | 0.560 |
Why?
|
Home Care Services | 1 | 2024 | 659 | 0.560 |
Why?
|
Professional Practice Location | 1 | 2017 | 57 | 0.560 |
Why?
|
Intensive Care Units | 4 | 2020 | 3800 | 0.550 |
Why?
|
Efficiency, Organizational | 5 | 2019 | 700 | 0.550 |
Why?
|
Interprofessional Relations | 6 | 2014 | 997 | 0.550 |
Why?
|
Developed Countries | 4 | 2024 | 452 | 0.540 |
Why?
|
Mortality | 4 | 2024 | 2917 | 0.540 |
Why?
|
Attitude of Health Personnel | 9 | 2017 | 3921 | 0.540 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 8 | 2017 | 92 | 0.530 |
Why?
|
Insurance, Pharmaceutical Services | 3 | 2016 | 348 | 0.530 |
Why?
|
Documentation | 3 | 2022 | 917 | 0.520 |
Why?
|
Opiate Substitution Treatment | 1 | 2020 | 452 | 0.520 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2027 | 0.510 |
Why?
|
Cohort Studies | 23 | 2024 | 41791 | 0.510 |
Why?
|
Guideline Adherence | 4 | 2014 | 2240 | 0.500 |
Why?
|
Critical Care | 3 | 2021 | 2716 | 0.500 |
Why?
|
Formularies as Topic | 2 | 2007 | 94 | 0.490 |
Why?
|
Fees, Medical | 1 | 2015 | 111 | 0.490 |
Why?
|
Leukemia | 1 | 2023 | 1526 | 0.490 |
Why?
|
Communication Barriers | 1 | 2018 | 419 | 0.490 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2023 | 1421 | 0.480 |
Why?
|
Laparotomy | 3 | 2015 | 458 | 0.480 |
Why?
|
Hypertension | 6 | 2023 | 8615 | 0.480 |
Why?
|
Patient Acceptance of Health Care | 4 | 2019 | 3230 | 0.480 |
Why?
|
Hip Fractures | 1 | 2023 | 996 | 0.480 |
Why?
|
Hospital Costs | 5 | 2020 | 957 | 0.480 |
Why?
|
Family Practice | 4 | 2007 | 511 | 0.470 |
Why?
|
Adult | 86 | 2024 | 223622 | 0.470 |
Why?
|
Middle Aged | 88 | 2024 | 223463 | 0.470 |
Why?
|
Inpatients | 3 | 2022 | 2569 | 0.470 |
Why?
|
Aftercare | 4 | 2024 | 920 | 0.470 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2015 | 155 | 0.470 |
Why?
|
Australia | 3 | 2022 | 1265 | 0.460 |
Why?
|
Risk Management | 2 | 2017 | 558 | 0.450 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2433 | 0.450 |
Why?
|
Health Benefit Plans, Employee | 6 | 2016 | 332 | 0.450 |
Why?
|
Colonoscopy | 5 | 2017 | 1412 | 0.440 |
Why?
|
Databases, Factual | 10 | 2020 | 8072 | 0.440 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 3541 | 0.440 |
Why?
|
Disease Management | 8 | 2016 | 2536 | 0.440 |
Why?
|
Models, Educational | 2 | 2017 | 375 | 0.440 |
Why?
|
Peer Group | 1 | 2019 | 698 | 0.440 |
Why?
|
Hepatitis | 1 | 2015 | 227 | 0.430 |
Why?
|
Ontario | 7 | 2023 | 403 | 0.430 |
Why?
|
Cost Control | 8 | 2020 | 627 | 0.430 |
Why?
|
Early Detection of Cancer | 6 | 2016 | 3236 | 0.420 |
Why?
|
Pandemics | 3 | 2024 | 8750 | 0.420 |
Why?
|
Spine | 2 | 2019 | 1141 | 0.410 |
Why?
|
Analgesics, Opioid | 4 | 2019 | 3836 | 0.410 |
Why?
|
Motivation | 1 | 2022 | 2029 | 0.410 |
Why?
|
Episode of Care | 1 | 2013 | 128 | 0.410 |
Why?
|
Internet | 4 | 2015 | 3107 | 0.410 |
Why?
|
Buprenorphine | 1 | 2020 | 666 | 0.410 |
Why?
|
Benzodiazepines | 1 | 2019 | 1139 | 0.410 |
Why?
|
Costs and Cost Analysis | 5 | 2023 | 1669 | 0.410 |
Why?
|
Health Plan Implementation | 1 | 2015 | 338 | 0.400 |
Why?
|
Respiratory Tract Infections | 3 | 2017 | 1014 | 0.400 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 2012 | 31 | 0.400 |
Why?
|
Drug Prescriptions | 2 | 2019 | 1673 | 0.390 |
Why?
|
Tissue Adhesions | 1 | 2013 | 223 | 0.390 |
Why?
|
Patient Care Planning | 1 | 2017 | 904 | 0.390 |
Why?
|
Antiretroviral Therapy, Highly Active | 7 | 2008 | 1903 | 0.380 |
Why?
|
Medical Informatics | 2 | 2017 | 739 | 0.380 |
Why?
|
Hospice Care | 2 | 2020 | 679 | 0.380 |
Why?
|
Internship and Residency | 4 | 2024 | 5948 | 0.370 |
Why?
|
Treatment Outcome | 23 | 2024 | 65365 | 0.370 |
Why?
|
Terminal Care | 3 | 2020 | 1773 | 0.360 |
Why?
|
Vascular Grafting | 1 | 2012 | 163 | 0.360 |
Why?
|
Hypnotics and Sedatives | 1 | 2019 | 1188 | 0.360 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 15652 | 0.350 |
Why?
|
Massachusetts | 18 | 2018 | 8902 | 0.350 |
Why?
|
Hernia, Ventral | 2 | 2013 | 192 | 0.340 |
Why?
|
Public Health Administration | 1 | 2012 | 242 | 0.340 |
Why?
|
Medically Uninsured | 4 | 2009 | 841 | 0.340 |
Why?
|
Models, Organizational | 5 | 2015 | 548 | 0.330 |
Why?
|
Chi-Square Distribution | 7 | 2019 | 3438 | 0.330 |
Why?
|
Trust | 4 | 2011 | 532 | 0.330 |
Why?
|
Online Systems | 1 | 2010 | 182 | 0.330 |
Why?
|
Electronic Health Records | 6 | 2023 | 4874 | 0.330 |
Why?
|
Hospital Bed Capacity | 2 | 2024 | 206 | 0.330 |
Why?
|
Mental Health | 3 | 2023 | 3276 | 0.320 |
Why?
|
Confusion | 1 | 2011 | 278 | 0.320 |
Why?
|
Postoperative Complications | 9 | 2022 | 15854 | 0.320 |
Why?
|
Language | 1 | 2018 | 1558 | 0.320 |
Why?
|
Choice Behavior | 3 | 2011 | 848 | 0.320 |
Why?
|
Mass Screening | 8 | 2019 | 5451 | 0.320 |
Why?
|
Rural Population | 2 | 2017 | 2318 | 0.310 |
Why?
|
Diffusion of Innovation | 2 | 2011 | 732 | 0.310 |
Why?
|
Research Design | 4 | 2022 | 6209 | 0.310 |
Why?
|
Program Evaluation | 2 | 2015 | 2505 | 0.300 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 390 | 0.290 |
Why?
|
Budgets | 3 | 2014 | 232 | 0.290 |
Why?
|
Private Practice | 1 | 2008 | 155 | 0.280 |
Why?
|
Decision Making | 6 | 2017 | 3953 | 0.280 |
Why?
|
Patient Participation | 3 | 2017 | 1448 | 0.280 |
Why?
|
Heart Failure | 3 | 2024 | 11860 | 0.270 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1946 | 0.270 |
Why?
|
Critical Illness | 3 | 2018 | 2755 | 0.270 |
Why?
|
Organizational Innovation | 6 | 2016 | 540 | 0.260 |
Why?
|
Coronary Artery Bypass | 4 | 2023 | 2194 | 0.260 |
Why?
|
Preventive Medicine | 3 | 2015 | 246 | 0.260 |
Why?
|
Orthopedic Procedures | 1 | 2016 | 1280 | 0.260 |
Why?
|
Surgicenters | 2 | 2017 | 50 | 0.260 |
Why?
|
Regression Analysis | 10 | 2017 | 6350 | 0.250 |
Why?
|
HIV Infections | 17 | 2009 | 17575 | 0.250 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2188 | 0.250 |
Why?
|
Attitude to Health | 3 | 2011 | 2025 | 0.250 |
Why?
|
Poverty | 5 | 2023 | 2721 | 0.250 |
Why?
|
Population Surveillance | 3 | 2019 | 2598 | 0.250 |
Why?
|
Benchmarking | 2 | 2019 | 1058 | 0.240 |
Why?
|
Israel | 2 | 2022 | 727 | 0.240 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3108 | 0.240 |
Why?
|
Telemedicine | 3 | 2018 | 3107 | 0.240 |
Why?
|
Propensity Score | 6 | 2019 | 1955 | 0.240 |
Why?
|
Interinstitutional Relations | 2 | 2017 | 236 | 0.240 |
Why?
|
Cardiotonic Agents | 1 | 2007 | 544 | 0.240 |
Why?
|
Organizational Culture | 3 | 2022 | 512 | 0.230 |
Why?
|
Education, Continuing | 1 | 2005 | 115 | 0.230 |
Why?
|
Logistic Models | 14 | 2020 | 13323 | 0.230 |
Why?
|
Age Factors | 10 | 2019 | 18472 | 0.220 |
Why?
|
Risk Sharing, Financial | 3 | 2019 | 47 | 0.220 |
Why?
|
New York | 6 | 2023 | 884 | 0.220 |
Why?
|
Cost Sharing | 2 | 2020 | 409 | 0.220 |
Why?
|
Career Mobility | 1 | 2006 | 262 | 0.220 |
Why?
|
Advanced Practice Nursing | 1 | 2023 | 18 | 0.220 |
Why?
|
Malpractice | 2 | 2022 | 561 | 0.210 |
Why?
|
Time Factors | 14 | 2020 | 40267 | 0.210 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2022 | 1517 | 0.210 |
Why?
|
Marketing of Health Services | 4 | 2011 | 151 | 0.210 |
Why?
|
Employee Performance Appraisal | 1 | 2003 | 86 | 0.210 |
Why?
|
Professional Practice | 2 | 2015 | 314 | 0.210 |
Why?
|
Life Expectancy | 2 | 2021 | 1249 | 0.210 |
Why?
|
Patient Selection | 4 | 2021 | 4265 | 0.210 |
Why?
|
Health Status | 6 | 2020 | 4094 | 0.210 |
Why?
|
Fellowships and Scholarships | 2 | 2011 | 1133 | 0.210 |
Why?
|
Health Policy | 5 | 2017 | 2698 | 0.210 |
Why?
|
Data Collection | 9 | 2014 | 3324 | 0.210 |
Why?
|
Cholinergic Antagonists | 1 | 2023 | 167 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.200 |
Why?
|
Education, Medical, Graduate | 2 | 2013 | 2411 | 0.200 |
Why?
|
Specialty Boards | 1 | 2024 | 236 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
Economics, Hospital | 3 | 2020 | 210 | 0.200 |
Why?
|
Quality Improvement | 6 | 2022 | 3858 | 0.200 |
Why?
|
Fee Schedules | 1 | 2022 | 87 | 0.200 |
Why?
|
Risk Assessment | 8 | 2019 | 24316 | 0.200 |
Why?
|
Patient Care Team | 5 | 2017 | 2529 | 0.200 |
Why?
|
Young Adult | 19 | 2021 | 60048 | 0.200 |
Why?
|
Education, Medical, Continuing | 3 | 2008 | 828 | 0.200 |
Why?
|
Organizations | 1 | 2022 | 172 | 0.190 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39405 | 0.190 |
Why?
|
Residence Characteristics | 5 | 2016 | 2122 | 0.190 |
Why?
|
Odds Ratio | 7 | 2020 | 9681 | 0.190 |
Why?
|
Financing, Personal | 2 | 2016 | 310 | 0.190 |
Why?
|
Ambulatory Care Facilities | 4 | 2009 | 940 | 0.190 |
Why?
|
Provider-Sponsored Organizations | 2 | 2016 | 12 | 0.190 |
Why?
|
Health Facilities, Proprietary | 1 | 2001 | 37 | 0.190 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2021 | 54 | 0.190 |
Why?
|
Hospital Administration | 2 | 2017 | 353 | 0.180 |
Why?
|
Syncope | 1 | 2024 | 430 | 0.180 |
Why?
|
Cooperative Behavior | 6 | 2016 | 1515 | 0.180 |
Why?
|
Interviews as Topic | 7 | 2017 | 2740 | 0.180 |
Why?
|
Unnecessary Procedures | 2 | 2015 | 419 | 0.180 |
Why?
|
Organizations, Nonprofit | 1 | 2001 | 105 | 0.180 |
Why?
|
Appointments and Schedules | 2 | 2023 | 442 | 0.180 |
Why?
|
Multivariate Analysis | 9 | 2017 | 12092 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2011 | 4047 | 0.180 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2014 | 2044 | 0.180 |
Why?
|
Alzheimer Disease | 1 | 2021 | 8747 | 0.170 |
Why?
|
Boston | 8 | 2013 | 9371 | 0.170 |
Why?
|
Salaries and Fringe Benefits | 3 | 2018 | 262 | 0.170 |
Why?
|
Medical Records | 4 | 2017 | 1413 | 0.170 |
Why?
|
Mammography | 3 | 2015 | 2434 | 0.170 |
Why?
|
Patient Care Management | 1 | 2003 | 304 | 0.160 |
Why?
|
Health Facility Merger | 1 | 2020 | 47 | 0.160 |
Why?
|
Health Promotion | 3 | 2020 | 2209 | 0.160 |
Why?
|
Severity of Illness Index | 6 | 2018 | 15939 | 0.160 |
Why?
|
Myocardial Revascularization | 1 | 2023 | 796 | 0.160 |
Why?
|
Biomedical Research | 3 | 2011 | 3464 | 0.160 |
Why?
|
Reoperation | 4 | 2015 | 4340 | 0.160 |
Why?
|
Medical Oncology | 2 | 2023 | 2348 | 0.160 |
Why?
|
Calcium Channel Blockers | 1 | 2022 | 692 | 0.160 |
Why?
|
State Government | 2 | 2016 | 389 | 0.160 |
Why?
|
Outpatients | 2 | 2021 | 1603 | 0.160 |
Why?
|
Incidence | 6 | 2019 | 21544 | 0.150 |
Why?
|
Self-Assessment | 1 | 2001 | 401 | 0.150 |
Why?
|
Housing | 1 | 2023 | 680 | 0.150 |
Why?
|
Community Health Services | 2 | 2017 | 659 | 0.150 |
Why?
|
Terminally Ill | 1 | 2020 | 240 | 0.150 |
Why?
|
Insurance Benefits | 1 | 2019 | 187 | 0.150 |
Why?
|
Endoscopy | 1 | 2008 | 1856 | 0.150 |
Why?
|
Counseling | 2 | 2016 | 1553 | 0.150 |
Why?
|
Attitude | 1 | 2003 | 772 | 0.150 |
Why?
|
Sampling Studies | 3 | 2015 | 616 | 0.150 |
Why?
|
Plant Leaves | 1 | 2018 | 153 | 0.140 |
Why?
|
Neoplasms | 4 | 2020 | 22389 | 0.140 |
Why?
|
Internationality | 1 | 2023 | 1008 | 0.140 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 876 | 0.140 |
Why?
|
Cognition Disorders | 1 | 2011 | 3985 | 0.140 |
Why?
|
Economics, Medical | 2 | 2007 | 112 | 0.140 |
Why?
|
Educational Measurement | 1 | 2024 | 1256 | 0.140 |
Why?
|
Physicians' Offices | 1 | 2017 | 60 | 0.140 |
Why?
|
Workplace | 2 | 2021 | 872 | 0.140 |
Why?
|
Thienopyridines | 1 | 2016 | 9 | 0.140 |
Why?
|
Syndrome | 1 | 2023 | 3275 | 0.140 |
Why?
|
Physician Executives | 2 | 2008 | 137 | 0.140 |
Why?
|
Current Procedural Terminology | 1 | 2017 | 101 | 0.140 |
Why?
|
Patients | 2 | 2014 | 909 | 0.140 |
Why?
|
Social Class | 3 | 2021 | 2008 | 0.130 |
Why?
|
Oregon | 2 | 2007 | 149 | 0.130 |
Why?
|
Pancreatectomy | 1 | 2021 | 823 | 0.130 |
Why?
|
Canada | 4 | 2022 | 2139 | 0.130 |
Why?
|
Colorectal Neoplasms | 3 | 2016 | 6969 | 0.130 |
Why?
|
Risk Factors | 15 | 2024 | 74954 | 0.130 |
Why?
|
Sulfonylurea Compounds | 1 | 2018 | 220 | 0.130 |
Why?
|
Mandatory Programs | 1 | 2016 | 86 | 0.130 |
Why?
|
Treatment Refusal | 2 | 2013 | 432 | 0.130 |
Why?
|
Comorbidity | 4 | 2022 | 10588 | 0.130 |
Why?
|
Longitudinal Studies | 5 | 2017 | 14783 | 0.130 |
Why?
|
Adolescent | 21 | 2021 | 89182 | 0.130 |
Why?
|
Nephrectomy | 1 | 2021 | 949 | 0.130 |
Why?
|
England | 2 | 2016 | 532 | 0.130 |
Why?
|
Peripheral Arterial Disease | 2 | 2017 | 1303 | 0.130 |
Why?
|
Intestinal Perforation | 1 | 2017 | 253 | 0.120 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2783 | 0.120 |
Why?
|
Social Support | 4 | 2016 | 2190 | 0.120 |
Why?
|
Occult Blood | 3 | 2016 | 199 | 0.120 |
Why?
|
Poliomyelitis | 1 | 2016 | 92 | 0.120 |
Why?
|
Sex Factors | 4 | 2019 | 10656 | 0.120 |
Why?
|
Supreme Court Decisions | 1 | 2016 | 135 | 0.120 |
Why?
|
Pneumonia | 1 | 2006 | 2162 | 0.120 |
Why?
|
Ownership | 2 | 2012 | 344 | 0.120 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8051 | 0.120 |
Why?
|
Continuity of Patient Care | 4 | 2024 | 1076 | 0.120 |
Why?
|
Contract Services | 2 | 2011 | 90 | 0.120 |
Why?
|
Research | 2 | 2015 | 1981 | 0.120 |
Why?
|
Breast | 1 | 2023 | 1975 | 0.120 |
Why?
|
Drug Approval | 1 | 2021 | 818 | 0.120 |
Why?
|
Community Mental Health Services | 1 | 2017 | 388 | 0.120 |
Why?
|
Decompression, Surgical | 1 | 2019 | 610 | 0.110 |
Why?
|
Neck Pain | 1 | 2016 | 191 | 0.110 |
Why?
|
Intermittent Claudication | 1 | 2016 | 305 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2019 | 1195 | 0.110 |
Why?
|
Aorta, Abdominal | 1 | 2016 | 627 | 0.110 |
Why?
|
Shock, Septic | 1 | 2020 | 774 | 0.110 |
Why?
|
Linear Models | 8 | 2021 | 5878 | 0.110 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1280 | 0.110 |
Why?
|
Veterans Health | 1 | 2015 | 215 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2007 | 664 | 0.110 |
Why?
|
Medicare Assignment | 1 | 2013 | 9 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2016 | 219 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 712 | 0.110 |
Why?
|
Coronary Disease | 1 | 2007 | 5926 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1672 | 0.110 |
Why?
|
Models, Theoretical | 2 | 2015 | 3579 | 0.100 |
Why?
|
Prostatectomy | 1 | 2021 | 1841 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 790 | 0.100 |
Why?
|
Patient Preference | 1 | 2020 | 947 | 0.100 |
Why?
|
Qualitative Research | 4 | 2017 | 3131 | 0.100 |
Why?
|
Independent Practice Associations | 3 | 2002 | 21 | 0.100 |
Why?
|
Minnesota | 4 | 2005 | 338 | 0.100 |
Why?
|
Education, Medical | 2 | 2007 | 1742 | 0.100 |
Why?
|
Drug Utilization | 2 | 2016 | 1191 | 0.100 |
Why?
|
Blood Vessel Prosthesis | 1 | 2017 | 957 | 0.100 |
Why?
|
Utilization Review | 3 | 2013 | 384 | 0.100 |
Why?
|
Health Facility Size | 1 | 2012 | 61 | 0.100 |
Why?
|
Acute Disease | 3 | 2015 | 7242 | 0.100 |
Why?
|
Family | 2 | 2022 | 3208 | 0.100 |
Why?
|
Medical Records Systems, Computerized | 2 | 2008 | 1196 | 0.100 |
Why?
|
Health Facilities | 1 | 2016 | 577 | 0.090 |
Why?
|
Stents | 2 | 2017 | 3201 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2015 | 497 | 0.090 |
Why?
|
Prospective Payment System | 1 | 2012 | 136 | 0.090 |
Why?
|
Models, Econometric | 2 | 2017 | 215 | 0.090 |
Why?
|
Protease Inhibitors | 2 | 2004 | 752 | 0.090 |
Why?
|
Trauma Severity Indices | 1 | 2012 | 479 | 0.090 |
Why?
|
Survival Rate | 3 | 2019 | 12870 | 0.090 |
Why?
|
Communication | 4 | 2022 | 3912 | 0.090 |
Why?
|
Metformin | 1 | 2018 | 911 | 0.090 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2015 | 470 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1126 | 0.080 |
Why?
|
Spinal Fusion | 1 | 2019 | 1309 | 0.080 |
Why?
|
Physical Therapy Modalities | 1 | 2013 | 533 | 0.080 |
Why?
|
Hospitals, Urban | 1 | 2012 | 500 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2015 | 21163 | 0.080 |
Why?
|
Physician's Role | 2 | 2012 | 926 | 0.080 |
Why?
|
Blood Pressure | 2 | 2023 | 8541 | 0.080 |
Why?
|
Developing Countries | 1 | 2022 | 2903 | 0.080 |
Why?
|
Registries | 3 | 2022 | 8378 | 0.080 |
Why?
|
Acetaminophen | 1 | 2013 | 556 | 0.080 |
Why?
|
Cost-Benefit Analysis | 4 | 2020 | 5538 | 0.080 |
Why?
|
Computer Simulation | 2 | 2020 | 6277 | 0.080 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1292 | 0.080 |
Why?
|
Search Engine | 1 | 2010 | 142 | 0.080 |
Why?
|
Patient Compliance | 2 | 2011 | 2693 | 0.080 |
Why?
|
Perception | 2 | 2017 | 1206 | 0.080 |
Why?
|
Lower Extremity | 1 | 2016 | 1218 | 0.080 |
Why?
|
Group Purchasing | 1 | 2007 | 9 | 0.080 |
Why?
|
Child Health Services | 1 | 2013 | 645 | 0.080 |
Why?
|
Child | 10 | 2023 | 80894 | 0.080 |
Why?
|
Morbidity | 1 | 2013 | 1758 | 0.070 |
Why?
|
Medically Underserved Area | 2 | 2007 | 266 | 0.070 |
Why?
|
Sigmoidoscopy | 1 | 2008 | 151 | 0.070 |
Why?
|
Enema | 1 | 2008 | 141 | 0.070 |
Why?
|
Ischemia | 1 | 2016 | 1900 | 0.070 |
Why?
|
Substance-Related Disorders | 2 | 2018 | 4429 | 0.070 |
Why?
|
Reminder Systems | 1 | 2011 | 387 | 0.070 |
Why?
|
Government Regulation | 1 | 2012 | 525 | 0.070 |
Why?
|
Insurance, Hospitalization | 1 | 2007 | 30 | 0.070 |
Why?
|
General Surgery | 1 | 2019 | 1712 | 0.070 |
Why?
|
Health Care Coalitions | 1 | 2007 | 36 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2018 | 1402 | 0.070 |
Why?
|
Case Management | 2 | 2009 | 276 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6541 | 0.070 |
Why?
|
Commerce | 2 | 2013 | 612 | 0.070 |
Why?
|
Intraoperative Complications | 2 | 2017 | 1174 | 0.070 |
Why?
|
Pilot Projects | 2 | 2010 | 8730 | 0.070 |
Why?
|
Awareness | 1 | 2011 | 653 | 0.070 |
Why?
|
Psychiatry | 1 | 2019 | 1715 | 0.070 |
Why?
|
Drug Utilization Review | 1 | 2007 | 248 | 0.060 |
Why?
|
Demography | 1 | 2011 | 1642 | 0.060 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1629 | 0.060 |
Why?
|
Prescription Fees | 1 | 2007 | 153 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14736 | 0.060 |
Why?
|
Nurses | 1 | 2015 | 2494 | 0.060 |
Why?
|
Cognition | 1 | 2023 | 7074 | 0.060 |
Why?
|
Hospitals, Teaching | 2 | 2009 | 1155 | 0.060 |
Why?
|
Vaccination | 2 | 2016 | 3431 | 0.060 |
Why?
|
Health Personnel | 3 | 2015 | 3381 | 0.060 |
Why?
|
Medical Audit | 1 | 2007 | 454 | 0.060 |
Why?
|
Pharmaceutical Preparations | 1 | 2014 | 1088 | 0.060 |
Why?
|
Safety | 1 | 2010 | 1159 | 0.060 |
Why?
|
Quality Control | 1 | 2008 | 833 | 0.060 |
Why?
|
Professional Autonomy | 2 | 2004 | 172 | 0.060 |
Why?
|
Vaginal Smears | 1 | 2008 | 505 | 0.060 |
Why?
|
Hospitals, Chronic Disease | 1 | 2004 | 8 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3643 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2005 | 2202 | 0.060 |
Why?
|
ROC Curve | 2 | 2011 | 3622 | 0.060 |
Why?
|
Aspirin | 1 | 2016 | 3136 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2019 | 3440 | 0.060 |
Why?
|
Florida | 2 | 2017 | 430 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 2763 | 0.060 |
Why?
|
Organizational Case Studies | 3 | 2012 | 301 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 887 | 0.060 |
Why?
|
Physicians, Women | 1 | 2010 | 520 | 0.060 |
Why?
|
Patient Transfer | 1 | 2011 | 793 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2010 | 2363 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2277 | 0.050 |
Why?
|
Nursing Staff, Hospital | 1 | 2006 | 350 | 0.050 |
Why?
|
Mental Disorders | 2 | 2017 | 6876 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6856 | 0.050 |
Why?
|
Algorithms | 3 | 2014 | 14154 | 0.050 |
Why?
|
Risk | 1 | 2015 | 9635 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2015 | 7453 | 0.050 |
Why?
|
Practice Management | 1 | 2003 | 37 | 0.050 |
Why?
|
Clinical Medicine | 1 | 2004 | 145 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2001 | 6238 | 0.050 |
Why?
|
New Zealand | 1 | 2023 | 360 | 0.050 |
Why?
|
Child, Preschool | 7 | 2016 | 42654 | 0.050 |
Why?
|
Migraine Disorders | 1 | 2015 | 1713 | 0.050 |
Why?
|
Age Distribution | 1 | 2008 | 2877 | 0.050 |
Why?
|
Infant | 6 | 2016 | 36512 | 0.050 |
Why?
|
Parents | 1 | 2016 | 3596 | 0.050 |
Why?
|
Wound Healing | 1 | 2013 | 2812 | 0.050 |
Why?
|
Patient Education as Topic | 2 | 2010 | 2337 | 0.050 |
Why?
|
Social Responsibility | 1 | 2004 | 384 | 0.050 |
Why?
|
Lipid Regulating Agents | 1 | 2021 | 21 | 0.050 |
Why?
|
Vaginal Discharge | 1 | 2001 | 25 | 0.050 |
Why?
|
New South Wales | 1 | 2021 | 69 | 0.050 |
Why?
|
Employment | 1 | 2007 | 1116 | 0.050 |
Why?
|
Models, Statistical | 4 | 2021 | 5099 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3707 | 0.050 |
Why?
|
Low Back Pain | 1 | 2009 | 989 | 0.040 |
Why?
|
Pediatrics | 1 | 2015 | 3624 | 0.040 |
Why?
|
Substance Abuse, Intravenous | 1 | 2005 | 530 | 0.040 |
Why?
|
Arizona | 1 | 2019 | 108 | 0.040 |
Why?
|
Women's Health | 2 | 2007 | 2078 | 0.040 |
Why?
|
Curriculum | 1 | 2013 | 3775 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2005 | 962 | 0.040 |
Why?
|
Maintenance | 1 | 2019 | 25 | 0.040 |
Why?
|
Health Services Administration | 1 | 2000 | 63 | 0.040 |
Why?
|
Economic Competition | 1 | 2001 | 223 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15455 | 0.040 |
Why?
|
Self Care | 1 | 2004 | 797 | 0.040 |
Why?
|
Information Systems | 1 | 2001 | 399 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2011 | 2542 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2016 | 26410 | 0.040 |
Why?
|
Rhode Island | 1 | 2019 | 353 | 0.040 |
Why?
|
Reproducibility of Results | 6 | 2019 | 20224 | 0.040 |
Why?
|
Feedback | 1 | 2002 | 795 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15868 | 0.040 |
Why?
|
Planning Techniques | 1 | 1998 | 81 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7458 | 0.040 |
Why?
|
New England | 2 | 2011 | 1058 | 0.040 |
Why?
|
Cholesterol, LDL | 2 | 2019 | 2398 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2022 | 647 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2002 | 609 | 0.040 |
Why?
|
Prostatic Hyperplasia | 1 | 2001 | 522 | 0.040 |
Why?
|
Attitude to Death | 1 | 2020 | 401 | 0.040 |
Why?
|
Urban Health Services | 1 | 2017 | 177 | 0.030 |
Why?
|
Mental Health Services | 1 | 2008 | 1731 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2007 | 2661 | 0.030 |
Why?
|
Poverty Areas | 1 | 2017 | 265 | 0.030 |
Why?
|
Specialties, Surgical | 1 | 2001 | 393 | 0.030 |
Why?
|
Annual Reports as Topic | 1 | 2015 | 36 | 0.030 |
Why?
|
Prospective Studies | 5 | 2020 | 54921 | 0.030 |
Why?
|
Insurance | 1 | 2017 | 115 | 0.030 |
Why?
|
Private Sector | 1 | 2018 | 396 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2002 | 1397 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12239 | 0.030 |
Why?
|
Viral Load | 1 | 2004 | 3398 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 2001 | 1142 | 0.030 |
Why?
|
Medical Errors | 1 | 2022 | 1263 | 0.030 |
Why?
|
Rural Health Services | 1 | 2017 | 393 | 0.030 |
Why?
|
Matched-Pair Analysis | 1 | 2013 | 286 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12557 | 0.020 |
Why?
|
Asthma | 2 | 2009 | 6281 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2017 | 809 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2001 | 2487 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20766 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 1003 | 0.020 |
Why?
|
Small-Area Analysis | 1 | 2010 | 51 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3728 | 0.020 |
Why?
|
Holistic Health | 1 | 2010 | 48 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 824 | 0.020 |
Why?
|
Information Seeking Behavior | 1 | 2010 | 116 | 0.020 |
Why?
|
India | 1 | 2016 | 2324 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2727 | 0.020 |
Why?
|
Confidence Intervals | 2 | 2006 | 2931 | 0.020 |
Why?
|
Management Quality Circles | 1 | 2007 | 20 | 0.020 |
Why?
|
Health Status Disparities | 2 | 2010 | 1882 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2015 | 1440 | 0.020 |
Why?
|
Vaccines | 1 | 2016 | 842 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36849 | 0.020 |
Why?
|
Decision Making, Organizational | 1 | 2007 | 136 | 0.020 |
Why?
|
Pneumocystis carinii | 1 | 2007 | 72 | 0.020 |
Why?
|
Leadership | 1 | 2016 | 1395 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1642 | 0.020 |
Why?
|
Community-Based Participatory Research | 1 | 2009 | 223 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 434 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 2009 | 250 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6319 | 0.020 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2007 | 242 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2007 | 509 | 0.020 |
Why?
|
Health Literacy | 1 | 2010 | 468 | 0.020 |
Why?
|
Federal Government | 1 | 2006 | 266 | 0.010 |
Why?
|
Professional-Patient Relations | 1 | 2010 | 726 | 0.010 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 432 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2013 | 22292 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3252 | 0.010 |
Why?
|
Capital Financing | 1 | 2004 | 58 | 0.010 |
Why?
|
Selection Bias | 1 | 2005 | 360 | 0.010 |
Why?
|
Needs Assessment | 1 | 2010 | 1142 | 0.010 |
Why?
|
Focus Groups | 1 | 2010 | 1453 | 0.010 |
Why?
|
Financing, Government | 1 | 2006 | 473 | 0.010 |
Why?
|
Financial Management | 1 | 2004 | 161 | 0.010 |
Why?
|
Urban Population | 1 | 2010 | 2045 | 0.010 |
Why?
|
Information Services | 1 | 2001 | 238 | 0.010 |
Why?
|
Prejudice | 1 | 2004 | 574 | 0.010 |
Why?
|
Prognosis | 2 | 2002 | 30020 | 0.010 |
Why?
|
Health Behavior | 1 | 2010 | 2647 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2862 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2005 | 2596 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 2000 | 448 | 0.010 |
Why?
|
Health Care Sector | 1 | 2000 | 197 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2000 | 1004 | 0.010 |
Why?
|
Medication Adherence | 1 | 2009 | 2189 | 0.010 |
Why?
|
Primary Prevention | 1 | 2004 | 1187 | 0.010 |
Why?
|
Teaching | 1 | 2004 | 1172 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2708 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1476 | 0.010 |
Why?
|
Cholesterol | 1 | 2004 | 2912 | 0.010 |
Why?
|
Research Personnel | 1 | 2000 | 590 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 2948 | 0.010 |
Why?
|
Tuberculosis | 1 | 2007 | 2029 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 13019 | 0.010 |
Why?
|